The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Facts Goldtrig? Didn’t you post on AVCT this morning regarding the South African Strain (known as 20H/501Y.V2 or B.1.351) using a link as evidence which made absolutely no reference or relevance to it to make your point?
I see Avacta Group has announced that the AffiDX SARS-CoV-2 rapid antigen lateral flow test detects the dominant new variants of the coronavirus, known as the B117, or ‘Kent’, variant, and the D614G variant, as well as the original strain?
Care to enlighten us?
Bored of talking to touchy trig, some people are so blinkered they can’t see the big world outside of their own little one. These are people who you can’t have a reasoned conversation with and not worth the time.
Most are calm, reasoned and objective...a few might be a little excitable. You will notice I’m not talking over on AVCT as I’m not invested and don’t think it’s necessary to force my opinion on them. When we get a stray over here for no good reason then that’s different.
Touchy...a true AVCT supporter
AVCT mcap is based so much on presumed success going forward that it wont take much for that pack of cards to come crashing down. At least here there is some value based upon the test, its largely based upon the work done to date and virtually nothing for what could come in the near future.
Reposting for new investors GAL
Marmited great post really appreciate your contributions.
Totally agree. antigen tests are not as sensitive as a PCR test which can pick up minuscule amounts of the SARS-CoV-2 virus that causes COVID-19 and therefore relying on quick antigen tests will never end the cycle of a twice monthly mutating virus as it will always have many places to hide.
Blimey! Wait a minute, RNS’s and the Professor tweets show that BRH’s test can compete with PCR testing, down to just finding just 100 particles in a 0.1 ml sample yet do it dramatically quicker, cheaper, future proof platform tech and in a extremely user friendly non clinical way.
Who would want such a crap system that does everything the world desperately needs yet does not have! Pfff.
terrine
Absolutely there is a Global market ! Brazil especially could do with our test right now as the President there has let the virus get out of control by initially denying the importance of face masks and social distancing ! They are dying at one of the highest rates in the World !
It won’t be just U.K. Government contracts we will be tendering for the whole world’s countries will be desperate to purchase millions of our RAPID 2 MINUTE COVID-19 AND MUTATIONS device ! There is no other test as fast and accurate as our Paraytec Braveheart Test IMO DYOR
I don’t do deramping, I am having an honest conversation with you. 1 in 30 missed positives! Not great is it! 3/4 of LFT’s will soon disappear and you will take up some DIY slack for sure IF your test is a huge improvement on current tests. But you are not going to be ‘the test’, no test is going to be THE test because the government have stated they need a RANGE.
I don’t have to prove anything, I couldn’t give a monkeys about AVCT. What I do know is that to end the pandemic we have to find all positive cases extremely quickly, a test that has the potential to miss so many positive cases and ultimately lead to death and harm will not last long even if it fills gap waiting for quality to emerge and surpass it.
To replace PCR’s... you have a lot of mud in your eyes.. no government in the world is going to replace PCR’s for a test that is far far far worse and that MISSES positive cases. Makes the whole point of testing an expensive complete waste of time.
What government would replace PCR’s with a nLFT that misses 1 in 30 positives?
Not yours though is it...
Novacyt tumbles after revealing dispute with UK government over supply contract extension
Well Well Well ! It seems highly likely that the UK Government has not extended its contracts with Novacyt for their Covid-19 test devices ! I wonder why ? Perhaps they have had a demo of our superior Paraytec device and arew withholding funding to go with our wholly owned sub company Paraytec
See the link below
https://www.proactiveinvestors.co.uk/companies/news/946140/novacyt-tumbles-after-revealing-dispute-with-uk-government-over-supply-contract-extension-946140.html